NCT04106817View on ClinicalTrials.gov

Single Ascending Dose Challenge Study to Determine Safety and Reactogenicity of an Influenza Challenge Virus

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 19, 2015

Primary Completion Date

August 10, 2015

Study Completion Date

August 10, 2015

Conditions
Influenza
Interventions
BIOLOGICAL

Live, wild-type A/California/H1N1 2009 influenza virus

Live, wild type influenza A virus that was inoculated and manufactured in allantoic fluid of SPF embryonated hen eggs

Sponsors

Lead Sponsor

WCCT Global
All Listed Sponsors
collaborator

Stanford University

OTHER

collaborator

National Institutes of Health (NIH)

NIH

lead

WCCT Global

INDUSTRY

NCT04106817 - Single Ascending Dose Challenge Study to Determine Safety and Reactogenicity of an Influenza Challenge Virus | Biotech Hunter | Biotech Hunter